Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Biol Ther. 2002 Jul-Aug;1(4):330-6.

EWS-FLI1 and Ewing's sarcoma: recent molecular data and new insights.

Author information

  • 1Dept. of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. ladanyim@mskcc.org

Abstract

The EWS-FLI1 fusion resulting from the specific t(11;22)(q24;q12) of Ewing's sarcoma was the first sarcoma gene fusion to be cloned, a decade ago. Moving from the cloning of this oncogenic chimeric transcription factor to the further elucidation of its pathogenetic mechanisms has revealed new complexities in the biology of this tumor which may be relevant to other fusion oncogenes as well. The present review highlights recent advances in three avenues of investigation that are providing new insights into this particular neoplasm and into the biology of EWS-FLI1 and related fusion proteins, namely the identification of various mitogenic targets of this aberrant transcription factor, its possible role as a deregulator of splicing, and the role of the p53 pathway in modulating its oncogenicity.

PMID:
12432241
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Landes Bioscience
    Loading ...
    Write to the Help Desk